FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021087951> ?p ?o ?g. }

• W2021087951 endingPage "75" @default.
• W2021087951 startingPage "62" @default.
• W2021087951 abstract "Cytoskeletal protein (CSP) interactions are critical to the contractile response in muscle and non-muscle cells. Current concepts suggest that activation of the contractile apparatus occurs through selective phosphorylation by specific cellular kinase systems. Because the Ca2+-phospholipid-dependent protein kinase C (PKC) is involved in the regulation of a number of key endothelial cell responses, the hypothesis that PKC modulates endothelial cell contraction and monolayer permeability was tested. Phorbol myristate acetate (PMA), a direct PKC activator, and α-thrombin, a receptor-mediated agonist known to increase endothelial cell permeability, both induced rapid, dose-dependent activation and translocation of PKC in bovine pulmonary artery endothelial cells (BPAEC), as assessed by γ-[32P]ATP phosphorylation of H1 histone in cellular fractions. This activation was temporally associated with evidence of agonist-mediated endothelial cell contraction as demonstrated by characteristic changes in cellular morphology. Agonist-induced activation of the contractile apparatus was associated with increases in BPAEC monolayer permeability to albumin (∼200% increase with 10−6 M PMA, ∼400% increase with 10−8 M α-thrombin). To more closely examine the role of PKC in activation of the contractile apparatus, PKC-mediated phosphorylation of two specific CSPs, the actin- and calmodulin-binding protein, caldesmon77, and the intermediate filament protein, vimentin, was assessed. In vitro phosphorylation of both caldesmon and vimentin was demonstrated by addition of exogenous, purified BPAEC PKC to unstimulated BPAEC homogenates, to purified bovine platelet caldesmon77, or to purified smooth muscle caldesmon150. Caldesmon77 and vimentin phosphorylation were observed in intact [32P]-labeled BPAEC monolayers stimulated with either PMA or α-thrombin, as detected by immunoprecipitation. In addition, BPAEC pretreatment with the PKC inhibitor, staurosporine, prevented α-thrombin- and PMA-induced phosphorylation of both cytoskeletal proteins, attenuated morphologic evidence of contraction, and abolished agonist-induced barrier dysfunction. These results demonstrate that agonist-stimulated PKC activity results in cytoskeletal protein phosphorylation in BPAEC monolayers, an event which occurs in concert with agonist-mediated endothelial cell contraction and resultant barrier dysfunction. © 1992 Wiley-Liss, Inc." @default.
• W2021087951 created "2016-06-24" @default.
• W2021087951 creator A5043689884 @default.
• W2021087951 creator A5052491243 @default.
• W2021087951 creator A5067027338 @default.
• W2021087951 date "1992-10-01" @default.
• W2021087951 modified "2023-09-24" @default.
• W2021087951 title "Protein kinase C phosphorylates caldesmon77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers" @default.
• W2021087951 cites W1505772870 @default.
• W2021087951 cites W1518494318 @default.
• W2021087951 cites W1520250133 @default.
• W2021087951 cites W1535139255 @default.
• W2021087951 cites W1542089964 @default.
• W2021087951 cites W1548149868 @default.
• W2021087951 cites W1558484374 @default.
• W2021087951 cites W1565313767 @default.
• W2021087951 cites W1589699489 @default.
• W2021087951 cites W1595787614 @default.
• W2021087951 cites W1605921103 @default.
• W2021087951 cites W1947815351 @default.
• W2021087951 cites W1964229279 @default.
• W2021087951 cites W1964368642 @default.
• W2021087951 cites W1964839077 @default.
• W2021087951 cites W1968247508 @default.
• W2021087951 cites W1970539529 @default.
• W2021087951 cites W1971631582 @default.
• W2021087951 cites W1985476658 @default.
• W2021087951 cites W1997093700 @default.
• W2021087951 cites W1999087572 @default.
• W2021087951 cites W2003416824 @default.
• W2021087951 cites W2009138813 @default.
• W2021087951 cites W2012197867 @default.
• W2021087951 cites W2014585326 @default.
• W2021087951 cites W2017348272 @default.
• W2021087951 cites W2020969716 @default.
• W2021087951 cites W2041216141 @default.
• W2021087951 cites W2048848497 @default.
• W2021087951 cites W2056382343 @default.
• W2021087951 cites W2077043119 @default.
• W2021087951 cites W2097611008 @default.
• W2021087951 cites W2105410040 @default.
• W2021087951 cites W2121229629 @default.
• W2021087951 cites W2122341536 @default.
• W2021087951 cites W2155813411 @default.
• W2021087951 cites W2161877684 @default.
• W2021087951 cites W2471331054 @default.
• W2021087951 cites W4232513362 @default.
• W2021087951 cites W4248750125 @default.
• W2021087951 doi "https://doi.org/10.1002/jcp.1041530110" @default.
• W2021087951 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1522136" @default.
• W2021087951 hasPublicationYear "1992" @default.
• W2021087951 type Work @default.
• W2021087951 sameAs 2021087951 @default.
• W2021087951 citedByCount "160" @default.
• W2021087951 countsByYear W20210879512012 @default.
• W2021087951 countsByYear W20210879512013 @default.
• W2021087951 countsByYear W20210879512014 @default.
• W2021087951 countsByYear W20210879512016 @default.
• W2021087951 countsByYear W20210879512017 @default.
• W2021087951 countsByYear W20210879512018 @default.
• W2021087951 countsByYear W20210879512019 @default.
• W2021087951 countsByYear W20210879512021 @default.
• W2021087951 crossrefType "journal-article" @default.
• W2021087951 hasAuthorship W2021087951A5043689884 @default.
• W2021087951 hasAuthorship W2021087951A5052491243 @default.
• W2021087951 hasAuthorship W2021087951A5067027338 @default.
• W2021087951 hasConcept C11960822 @default.
• W2021087951 hasConcept C123012128 @default.
• W2021087951 hasConcept C153911025 @default.
• W2021087951 hasConcept C195794163 @default.
• W2021087951 hasConcept C199217515 @default.
• W2021087951 hasConcept C202751555 @default.
• W2021087951 hasConcept C55493867 @default.
• W2021087951 hasConcept C86803240 @default.
• W2021087951 hasConcept C90934575 @default.
• W2021087951 hasConcept C95444343 @default.
• W2021087951 hasConcept C97029542 @default.
• W2021087951 hasConceptScore W2021087951C11960822 @default.
• W2021087951 hasConceptScore W2021087951C123012128 @default.
• W2021087951 hasConceptScore W2021087951C153911025 @default.
• W2021087951 hasConceptScore W2021087951C195794163 @default.
• W2021087951 hasConceptScore W2021087951C199217515 @default.
• W2021087951 hasConceptScore W2021087951C202751555 @default.
• W2021087951 hasConceptScore W2021087951C55493867 @default.
• W2021087951 hasConceptScore W2021087951C86803240 @default.
• W2021087951 hasConceptScore W2021087951C90934575 @default.
• W2021087951 hasConceptScore W2021087951C95444343 @default.
• W2021087951 hasConceptScore W2021087951C97029542 @default.
• W2021087951 hasIssue "1" @default.
• W2021087951 hasLocation W20210879511 @default.
• W2021087951 hasLocation W20210879512 @default.
• W2021087951 hasOpenAccess W2021087951 @default.
• W2021087951 hasPrimaryLocation W20210879511 @default.
• W2021087951 hasRelatedWork W1973191101 @default.
• W2021087951 hasRelatedWork W1979715535 @default.
• W2021087951 hasRelatedWork W1985042912 @default.
• W2021087951 hasRelatedWork W1998273541 @default.
• W2021087951 hasRelatedWork W2025409136 @default.

• next